: A top defensive choice combining retail stability with e-commerce upside; it has 53 years of consecutive dividend increases.
: Noted for its diverse medical device pipeline and recent spin-off of its diabetes unit to focus on higher-margin sales. Emerging Sector Opportunities available stocks to buy
: Analysts from Mutual of America and Fidelity suggest looking beyond the "Magnificent Seven" as mid- and small-cap earnings projections rise. : A top defensive choice combining retail stability
: A premium defensive stock with a 69-year track record of dividend growth. available stocks to buy
Growth stocks continue to power market gains, driven by digital transformation and AI-related capital expenditure.